1-2 April 2022
ProsTIC Preceptorship 2022
From Melbourne to the World

Preceptorship themes


What is the role of PSMA PET/CT in early stage prostate cancer?


Evidence-based PSMA​


Is PSMA PET/CT a new biomarker for optimising patient management?


Consumer advocates

Theranostic Suite

The Theranostic Suite: How we run it from 5 perspectives

PSMA Theranostics

The art of PSMA theranostics​


It is with delight and pleasure that I invite, and warmly welcome you to the inaugural ProsTIC Preceptorship 2022, in-person or online.

In line with one of our program’s key pillars of Education and Leadership, we are proud to present “How we do PSMA Theranostics”.

Together with multidisciplinary colleagues and world leading experts we will provide you with the latest in research, case studies, practical applications and the future of PSMA Imaging and Theranostics.  

We performed our first PSMA PET/CT in 2014, and our first Lutetium PSMA therapy in 2015. We will share with you how we, at the Peter MacCallum Cancer Centre, “do” our successful program, so you can to!

Kind regards,

Professor Michael Hofman
Chair, ProsTIC Preceptorship 2022
Director, Prostate Cancer Theranostics and Imaging Centre of Excellence

ProsTIC Preceptorship 2022

Join us at the Sofitel Melbourne on Collins and online. Plenary speakers will be joining us for two days sharing their knowledge and stories on the changing clinical world around us.

In Person Attendance

Sofitel Melbourne on Collins

25 Collins Street
Melbourne 3000

Online Access

Follow the prompts for virtual  attendance during registration. Full access details will be shared prior to the event. 

Accelerate clinical trial research

Accelerate clinical trial research

Expand the portfolio of clinical trials investigating the use of PSMA PET imaging and therapy targeting areas of high-impact need that are not currently being addressed.

Education & Leadership

Education & Leadership

Establish a global hub of excellence to educate doctors, scientists, patients and the community about the application and benefits of this new technology.

Discovery research

Discovery research

Further investigate next generation targets, develop biomarkers to predict and monitor response to PSMA therapy, optimise new combinations with PSMA therapy in pre-clinical models, explore the use of radio-guided surgery and artificial intelligence image interpretation.